Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 11 of 11 entries
Sorted by: Best Match Show Resources per page
Economic evaluation plan of a randomised controlled trial of intra-nodular injection of anti-TNF and placebo among patients with early Dupuytren's disease: Repurposing Anti-TNF for Treating Dupuytren's Disease (RIDD).

Wellcome open research

Png ME, Dritsaki M, Gray A, Pinedo-Villanueva R, Rivero-Arias O, Nanchahal J.
PMID: 30756094
Wellcome Open Res. 2018 Dec 07;3:156. doi: 10.12688/wellcomeopenres.14936.1. eCollection 2018.

Dupuytren's disease (DD) is a common fibroproliferative condition of the palmar and digital fascia of the hand; however, there is currently no approved treatment for early stage DD. The objective of this paper is to describe the methods applied...

Cite
Png ME, Dritsaki M, Gray A, et al. Economic evaluation plan of a randomised controlled trial of intra-nodular injection of anti-TNF and placebo among patients with early Dupuytren's disease: Repurposing Anti-TNF for Treating Dupuytren's Disease (RIDD). Wellcome Open Res. 2018;3:156doi: 10.12688/wellcomeopenres.14936.1.
Png, M. E., Dritsaki, M., Gray, A., Pinedo-Villanueva, R., Rivero-Arias, O., & Nanchahal, J. (2018). Economic evaluation plan of a randomised controlled trial of intra-nodular injection of anti-TNF and placebo among patients with early Dupuytren's disease: Repurposing Anti-TNF for Treating Dupuytren's Disease (RIDD). Wellcome open research, 3156. https://doi.org/10.12688/wellcomeopenres.14936.1
Png, May Ee, et al. "Economic evaluation plan of a randomised controlled trial of intra-nodular injection of anti-TNF and placebo among patients with early Dupuytren's disease: Repurposing Anti-TNF for Treating Dupuytren's Disease (RIDD)." Wellcome open research vol. 3 (2018): 156. doi: https://doi.org/10.12688/wellcomeopenres.14936.1
Png ME, Dritsaki M, Gray A, Pinedo-Villanueva R, Rivero-Arias O, Nanchahal J. Economic evaluation plan of a randomised controlled trial of intra-nodular injection of anti-TNF and placebo among patients with early Dupuytren's disease: Repurposing Anti-TNF for Treating Dupuytren's Disease (RIDD). Wellcome Open Res. 2018 Dec 07;3:156. doi: 10.12688/wellcomeopenres.14936.1. eCollection 2018. PMID: 30756094; PMCID: PMC6354323.
Copy Download .nbib Format: NLM
Comparing the Efficacy of a Mobile Phone-Based Blood Glucose Management System With Standard Clinic Care in Women With Gestational Diabetes: Randomized Controlled Trial.

JMIR mHealth and uHealth

Mackillop L, Hirst JE, Bartlett KJ, Birks JS, Clifton L, Farmer AJ, Gibson O, Kenworthy Y, Levy JC, Loerup L, Rivero-Arias O, Ming WK, Velardo C, Tarassenko L.
PMID: 29559428
JMIR Mhealth Uhealth. 2018 Mar 20;6(3):e71. doi: 10.2196/mhealth.9512.

BACKGROUND: Treatment of hyperglycemia in women with gestational diabetes mellitus (GDM) is associated with improved maternal and neonatal outcomes and requires intensive clinical input. This is currently achieved by hospital clinic attendance every 2 to 4 weeks with limited...

Cite
Mackillop L, Hirst JE, Bartlett KJ, et al. Comparing the Efficacy of a Mobile Phone-Based Blood Glucose Management System With Standard Clinic Care in Women With Gestational Diabetes: Randomized Controlled Trial. JMIR Mhealth Uhealth. 2018;6(3):e71doi: 10.2196/mhealth.9512.
Mackillop, L., Hirst, J. E., Bartlett, K. J., Birks, J. S., Clifton, L., Farmer, A. J., Gibson, O., Kenworthy, Y., Levy, J. C., Loerup, L., Rivero-Arias, O., Ming, W. K., Velardo, C., & Tarassenko, L. (2018). Comparing the Efficacy of a Mobile Phone-Based Blood Glucose Management System With Standard Clinic Care in Women With Gestational Diabetes: Randomized Controlled Trial. JMIR mHealth and uHealth, 6(3), e71. https://doi.org/10.2196/mhealth.9512
Mackillop, Lucy, et al. "Comparing the Efficacy of a Mobile Phone-Based Blood Glucose Management System With Standard Clinic Care in Women With Gestational Diabetes: Randomized Controlled Trial." JMIR mHealth and uHealth vol. 6,3 (2018): e71. doi: https://doi.org/10.2196/mhealth.9512
Mackillop L, Hirst JE, Bartlett KJ, Birks JS, Clifton L, Farmer AJ, Gibson O, Kenworthy Y, Levy JC, Loerup L, Rivero-Arias O, Ming WK, Velardo C, Tarassenko L. Comparing the Efficacy of a Mobile Phone-Based Blood Glucose Management System With Standard Clinic Care in Women With Gestational Diabetes: Randomized Controlled Trial. JMIR Mhealth Uhealth. 2018 Mar 20;6(3):e71. doi: 10.2196/mhealth.9512. PMID: 29559428; PMCID: PMC5883074.
Copy Download .nbib Format: NLM
Correction to: multiple imputation for patient reported outcome measures in randomised controlled trials: advantages and disadvantages of imputing at the item, subscale or composite score level.

BMC medical research methodology

Rombach I, Gray AM, Jenkinson C, Murray DW, Rivero-Arias O.
PMID: 30326839
BMC Med Res Methodol. 2018 Oct 16;18(1):107. doi: 10.1186/s12874-018-0563-1.

Following publication of the original article [1], the authors reported that the following notation wasn't used consistently.

Cite
Rombach I, Gray AM, Jenkinson C, et al. Correction to: multiple imputation for patient reported outcome measures in randomised controlled trials: advantages and disadvantages of imputing at the item, subscale or composite score level. BMC Med Res Methodol. 2018;18(1):107doi: 10.1186/s12874-018-0563-1.
Rombach, I., Gray, A. M., Jenkinson, C., Murray, D. W., & Rivero-Arias, O. (2018). Correction to: multiple imputation for patient reported outcome measures in randomised controlled trials: advantages and disadvantages of imputing at the item, subscale or composite score level. BMC medical research methodology, 18(1), 107. https://doi.org/10.1186/s12874-018-0563-1
Rombach, Ines, et al. "Correction to: multiple imputation for patient reported outcome measures in randomised controlled trials: advantages and disadvantages of imputing at the item, subscale or composite score level." BMC medical research methodology vol. 18,1 (2018): 107. doi: https://doi.org/10.1186/s12874-018-0563-1
Rombach I, Gray AM, Jenkinson C, Murray DW, Rivero-Arias O. Correction to: multiple imputation for patient reported outcome measures in randomised controlled trials: advantages and disadvantages of imputing at the item, subscale or composite score level. BMC Med Res Methodol. 2018 Oct 16;18(1):107. doi: 10.1186/s12874-018-0563-1. PMID: 30326839; PMCID: PMC6192362.
Copy Download .nbib Format: NLM
Comparison of statistical approaches for analyzing incomplete longitudinal patient-reported outcome data in randomized controlled trials.

Patient related outcome measures

Rombach I, Jenkinson C, Gray AM, Murray DW, Rivero-Arias O.
PMID: 29950913
Patient Relat Outcome Meas. 2018 Jun 21;9:197-209. doi: 10.2147/PROM.S147790. eCollection 2018.

PURPOSE: Missing data are a potential source of bias in the results of RCTs, but are often unavoidable in clinical research, particularly in patient-reported outcome measures (PROMs). Maximum likelihood (ML), multiple imputation (MI), and inverse probability weighting (IPW) can...

Cite
Rombach I, Jenkinson C, Gray AM, et al. Comparison of statistical approaches for analyzing incomplete longitudinal patient-reported outcome data in randomized controlled trials. Patient Relat Outcome Meas. 2018;9:197-209doi: 10.2147/PROM.S147790.
Rombach, I., Jenkinson, C., Gray, A. M., Murray, D. W., & Rivero-Arias, O. (2018). Comparison of statistical approaches for analyzing incomplete longitudinal patient-reported outcome data in randomized controlled trials. Patient related outcome measures, 9197-209. https://doi.org/10.2147/PROM.S147790
Rombach, Ines, et al. "Comparison of statistical approaches for analyzing incomplete longitudinal patient-reported outcome data in randomized controlled trials." Patient related outcome measures vol. 9 (2018): 197-209. doi: https://doi.org/10.2147/PROM.S147790
Rombach I, Jenkinson C, Gray AM, Murray DW, Rivero-Arias O. Comparison of statistical approaches for analyzing incomplete longitudinal patient-reported outcome data in randomized controlled trials. Patient Relat Outcome Meas. 2018 Jun 21;9:197-209. doi: 10.2147/PROM.S147790. eCollection 2018. PMID: 29950913; PMCID: PMC6016604.
Copy Download .nbib Format: NLM
Burden of disease and costs of aneurysmal subarachnoid haemorrhage (aSAH) in the United Kingdom.

Cost effectiveness and resource allocation : C/E

Rivero-Arias O, Gray A, Wolstenholme J.
PMID: 20423472
Cost Eff Resour Alloc. 2010 Apr 27;8:6. doi: 10.1186/1478-7547-8-6.

BACKGROUND: To estimate life years and quality-adjusted life years (QALYs) lost and the economic burden of aneurysmal subarachnoid haemorrhage (aSAH) in the United Kingdom including healthcare and non-healthcare costs from a societal perspective.METHODS: All UK residents in 2005 with...

Cite
Rivero-Arias O, Gray A, Wolstenholme J. Burden of disease and costs of aneurysmal subarachnoid haemorrhage (aSAH) in the United Kingdom. Cost Eff Resour Alloc. 2010;8:6doi: 10.1186/1478-7547-8-6.
Rivero-Arias, O., Gray, A., & Wolstenholme, J. (2010). Burden of disease and costs of aneurysmal subarachnoid haemorrhage (aSAH) in the United Kingdom. Cost effectiveness and resource allocation : C/E, 86. https://doi.org/10.1186/1478-7547-8-6
Rivero-Arias, Oliver, et al. "Burden of disease and costs of aneurysmal subarachnoid haemorrhage (aSAH) in the United Kingdom." Cost effectiveness and resource allocation : C/E vol. 8 (2010): 6. doi: https://doi.org/10.1186/1478-7547-8-6
Rivero-Arias O, Gray A, Wolstenholme J. Burden of disease and costs of aneurysmal subarachnoid haemorrhage (aSAH) in the United Kingdom. Cost Eff Resour Alloc. 2010 Apr 27;8:6. doi: 10.1186/1478-7547-8-6. PMID: 20423472; PMCID: PMC2874525.
Copy Download .nbib Format: NLM
Healthcare and wider societal implications of stillbirth: a population-based cost-of-illness study.

BJOG : an international journal of obstetrics and gynaecology

Campbell HE, Kurinczuk JJ, Heazell A, Leal J, Rivero-Arias O.
PMID: 29034559
BJOG. 2018 Jan;125(2):108-117. doi: 10.1111/1471-0528.14972. Epub 2017 Dec 14.

OBJECTIVE: To extend previous work and estimate health and social care costs, litigation costs, funeral-related costs, and productivity losses associated with stillbirth in the UK.DESIGN: A population-based cost-of-illness study using a synthesis of secondary data.SETTING: The National Health Service...

Cite
Campbell HE, Kurinczuk JJ, Heazell A, et al. Healthcare and wider societal implications of stillbirth: a population-based cost-of-illness study. BJOG. 2017;125(2):108-117doi: 10.1111/1471-0528.14972.
Campbell, H. E., Kurinczuk, J. J., Heazell, A., Leal, J., & Rivero-Arias, O. (2018). Healthcare and wider societal implications of stillbirth: a population-based cost-of-illness study. BJOG : an international journal of obstetrics and gynaecology, 125(2), 108-117. https://doi.org/10.1111/1471-0528.14972
Campbell, H E, et al. "Healthcare and wider societal implications of stillbirth: a population-based cost-of-illness study." BJOG : an international journal of obstetrics and gynaecology vol. 125,2 (2018): 108-117. doi: https://doi.org/10.1111/1471-0528.14972
Campbell HE, Kurinczuk JJ, Heazell A, Leal J, Rivero-Arias O. Healthcare and wider societal implications of stillbirth: a population-based cost-of-illness study. BJOG. 2018 Jan;125(2):108-117. doi: 10.1111/1471-0528.14972. Epub 2017 Dec 14. PMID: 29034559; PMCID: PMC5767761.
Copy Download .nbib Format: NLM
[Effect on quality of life of nCPAP treatment in patients with obstructive sleep apnea].

Medicina clinica

Mar J, Rivero-Arias O, Durán-Cantolla J, Alonso-Alvarez ML, Gaminde I, de la Torre-Muñecas G.
PMID: 16287570
Med Clin (Barc). 2005 Nov 05;125(16):611-5. doi: 10.1157/13080827.

BACKGROUND AND OBJECTIVE: The standard treatment of the obstructive sleep apnea syndrome (OSAS) is the nCPAP. There is evidence that its use improves the quality of life of patients. The objective of the study is to measure the effect...

Cite
Mar J, Rivero-Arias O, Durán-Cantolla J, et al. Efecto del tratamiento con presión positiva continua en la vía respiratoria durante la noche en la calidad de vida de los pacientes con apnea del sueño. [Effect on quality of life of nCPAP treatment in patients with obstructive sleep apnea]. Med Clin (Barc). 2005;125(16):611-5doi: 10.1157/13080827.
Mar, J., Rivero-Arias, O., Durán-Cantolla, J., Alonso-Alvarez, M. L., Gaminde, I., & de la Torre-Muñecas, G. (2005). Efecto del tratamiento con presión positiva continua en la vía respiratoria durante la noche en la calidad de vida de los pacientes con apnea del sueño. [Effect on quality of life of nCPAP treatment in patients with obstructive sleep apnea]. Medicina clinica, 125(16), 611-5. https://doi.org/10.1157/13080827
Mar, Javier, et al. "Efecto del tratamiento con presión positiva continua en la vía respiratoria durante la noche en la calidad de vida de los pacientes con apnea del sueño." [Effect on quality of life of nCPAP treatment in patients with obstructive sleep apnea]. Medicina clinica vol. 125,16 (2005): 611-5. doi: https://doi.org/10.1157/13080827
Mar J, Rivero-Arias O, Durán-Cantolla J, Alonso-Alvarez ML, Gaminde I, de la Torre-Muñecas G. Efecto del tratamiento con presión positiva continua en la vía respiratoria durante la noche en la calidad de vida de los pacientes con apnea del sueño. [Effect on quality of life of nCPAP treatment in patients with obstructive sleep apnea]. Med Clin (Barc). 2005 Nov 05;125(16):611-5. doi: 10.1157/13080827. Spanish. PMID: 16287570.
Copy Download .nbib Format: NLM
Evaluation of software for multiple imputation of semi-continuous data.

Statistical methods in medical research

Yu LM, Burton A, Rivero-Arias O.
PMID: 17621470
Stat Methods Med Res. 2007 Jun;16(3):243-58. doi: 10.1177/0962280206074464.

It is now widely accepted that multiple imputation (MI) methods properly handle the uncertainty of missing data over single imputation methods. Several standard statistical software packages, such as SAS, R and STATA, have standard procedures or user-written programs to...

Cite
Yu LM, Burton A, Rivero-Arias O. Evaluation of software for multiple imputation of semi-continuous data. Stat Methods Med Res. 2007;16(3):243-58doi: 10.1177/0962280206074464.
Yu, L. M., Burton, A., & Rivero-Arias, O. (2007). Evaluation of software for multiple imputation of semi-continuous data. Statistical methods in medical research, 16(3), 243-58. https://doi.org/10.1177/0962280206074464
Yu, L-M, et al. "Evaluation of software for multiple imputation of semi-continuous data." Statistical methods in medical research vol. 16,3 (2007): 243-58. doi: https://doi.org/10.1177/0962280206074464
Yu LM, Burton A, Rivero-Arias O. Evaluation of software for multiple imputation of semi-continuous data. Stat Methods Med Res. 2007 Jun;16(3):243-58. doi: 10.1177/0962280206074464. PMID: 17621470.
Copy Download .nbib Format: NLM
Preferred Reporting Items for Studies Mapping onto Preference-Based Outcome Measures: The MAPS Statement.

Medical decision making : an international journal of the Society for Medical Decision Making

Petrou S, Rivero-Arias O, Dakin H, Longworth L, Oppe M, Froud R, Gray A.
PMID: 29669469
Med Decis Making. 2015 Aug;35(6):NP1-NP8. doi: 10.1177/0272989X15598332.

BACKGROUND: "Mapping" onto generic preference-based outcome measures is increasingly being used as a means of generating health utilities for use within health economic evaluations. Despite the publication of technical guides for the conduct of mapping research, guidance for the...

Cite
Petrou S, Rivero-Arias O, Dakin H, et al. Preferred Reporting Items for Studies Mapping onto Preference-Based Outcome Measures: The MAPS Statement. Med Decis Making. 2015;35(6):NP1-NP8doi: 10.1177/0272989X15598332.
Petrou, S., Rivero-Arias, O., Dakin, H., Longworth, L., Oppe, M., Froud, R., & Gray, A. (2015). Preferred Reporting Items for Studies Mapping onto Preference-Based Outcome Measures: The MAPS Statement. Medical decision making : an international journal of the Society for Medical Decision Making, 35(6), NP1-NP8. https://doi.org/10.1177/0272989X15598332
Petrou, Stavros, et al. "Preferred Reporting Items for Studies Mapping onto Preference-Based Outcome Measures: The MAPS Statement." Medical decision making : an international journal of the Society for Medical Decision Making vol. 35,6 (2015): NP1-NP8. doi: https://doi.org/10.1177/0272989X15598332
Petrou S, Rivero-Arias O, Dakin H, Longworth L, Oppe M, Froud R, Gray A. Preferred Reporting Items for Studies Mapping onto Preference-Based Outcome Measures: The MAPS Statement. Med Decis Making. 2015 Aug;35(6):NP1-NP8. doi: 10.1177/0272989X15598332. PMID: 29669469.
Copy Download .nbib Format: NLM
Economic evaluation plan of a randomised controlled trial of intra-nodular injection of anti-TNF and placebo among patients with early Dupuytren's disease: Repurposing Anti-TNF for Treating Dupuytren's Disease (RIDD).

Wellcome open research

Png ME, Dritsaki M, Gray A, Pinedo-Villanueva R, Rivero-Arias O, Nanchahal J.
PMID: 30756094
Wellcome Open Res. 2019 Feb 12;3:156. doi: 10.12688/wellcomeopenres.14936.2. eCollection 2018.

Dupuytren's disease (DD) is a common fibroproliferative condition of the palmar and digital fascia of the hand; however, there is currently no approved treatment for early stage DD. The objective of this paper is to describe the methods applied...

Cite
Png ME, Dritsaki M, Gray A, et al. Economic evaluation plan of a randomised controlled trial of intra-nodular injection of anti-TNF and placebo among patients with early Dupuytren's disease: Repurposing Anti-TNF for Treating Dupuytren's Disease (RIDD). Wellcome Open Res. 2019;3:156doi: 10.12688/wellcomeopenres.14936.2.
Png, M. E., Dritsaki, M., Gray, A., Pinedo-Villanueva, R., Rivero-Arias, O., & Nanchahal, J. (2018). Economic evaluation plan of a randomised controlled trial of intra-nodular injection of anti-TNF and placebo among patients with early Dupuytren's disease: Repurposing Anti-TNF for Treating Dupuytren's Disease (RIDD). Wellcome open research, 3156. https://doi.org/10.12688/wellcomeopenres.14936.2
Png, May Ee, et al. "Economic evaluation plan of a randomised controlled trial of intra-nodular injection of anti-TNF and placebo among patients with early Dupuytren's disease: Repurposing Anti-TNF for Treating Dupuytren's Disease (RIDD)." Wellcome open research vol. 3 (2018): 156. doi: https://doi.org/10.12688/wellcomeopenres.14936.2
Png ME, Dritsaki M, Gray A, Pinedo-Villanueva R, Rivero-Arias O, Nanchahal J. Economic evaluation plan of a randomised controlled trial of intra-nodular injection of anti-TNF and placebo among patients with early Dupuytren's disease: Repurposing Anti-TNF for Treating Dupuytren's Disease (RIDD). Wellcome Open Res. 2019 Feb 12;3:156. doi: 10.12688/wellcomeopenres.14936.2. eCollection 2018. PMID: 30756094; PMCID: PMC6354323.
Copy Download .nbib Format: NLM
The way forward to a renewed and improved Health and Quality of Life Outcomes.

Health and quality of life outcomes

Oremus M, Rivero-Arias O.
PMID: 33794919
Health Qual Life Outcomes. 2021 Apr 01;19(1):109. doi: 10.1186/s12955-021-01746-4.

No abstract available.

Cite
Oremus M, Rivero-Arias O. The way forward to a renewed and improved Health and Quality of Life Outcomes. Health Qual Life Outcomes. 2021;19(1):109doi: 10.1186/s12955-021-01746-4.
Oremus, M., & Rivero-Arias, O. (2021). The way forward to a renewed and improved Health and Quality of Life Outcomes. Health and quality of life outcomes, 19(1), 109. https://doi.org/10.1186/s12955-021-01746-4
Oremus, Mark, and Rivero-Arias, Oliver. "The way forward to a renewed and improved Health and Quality of Life Outcomes." Health and quality of life outcomes vol. 19,1 (2021): 109. doi: https://doi.org/10.1186/s12955-021-01746-4
Oremus M, Rivero-Arias O. The way forward to a renewed and improved Health and Quality of Life Outcomes. Health Qual Life Outcomes. 2021 Apr 01;19(1):109. doi: 10.1186/s12955-021-01746-4. PMID: 33794919; PMCID: PMC8015164.
Copy Download .nbib Format: NLM
Showing 1 to 11 of 11 entries